Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Tkacz

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Public Health in Practice (Oxford, England)|September 14, 2022
Increasing rate of diagnosed childhood mental illness in the United States: Incidence, prevalence and costsJoseph Tkacz, Brenna L Brady
Journal of Substance Abuse Treatment|August 24, 2010
A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: study feasibility and sample descriptionCharles Ruetsch, John Cacciola, Joseph Tkacz
The American Journal of Managed Care|December 21, 2019
A claims-based algorithm to reduce relapse and cost in schizophreniaHeidi C Waters, Charles Ruetsch, Joseph Tkacz
Value in Health Regional Issues|April 3, 2026
Healthcare Resource Utilization and Costs After Disease Progression With First-Line Systemic Therapy in Patients With Advanced Endometrial Cancer in the United StatesLaura Moore-Schiltz, Solomon J Lubinga, Joseph Tkacz
Journal of Substance Abuse Treatment|December 17, 2013
Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patientsJoseph Tkacz, Joseph Volpicelli, Hyong Un, et al.
The American Journal on Addictions|January 4, 2012
Compliance with buprenorphine medication-assisted treatment and relapse to opioid useJoseph Tkacz, Jamie Severt, John Cacciola, et al.
Journal of Addictive Diseases|May 1, 2012
Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatmentJoseph Tkacz, Jamie Severt, Cheryl Kassed, et al.
The American Journal of Gastroenterology|June 16, 2021
Alarming Trends in Opioid Use Among Patients With GERDColin W Howden, Douglas C A Taylor, Joseph Tkacz
American Health & Drug Benefits|July 4, 2014
Infliximab dosing patterns in a sample of patients with Crohn's disease: results from a medical chart reviewJoseph Tkacz, Jennifer H Lofland, Julie Vanderpoel, et al.
Addictive Behaviors|February 22, 2012
The effect of telephonic patient support on treatment for opioid dependence: outcomes at one year follow-upCharles Ruetsch, Joseph Tkacz, Tracy L McPherson, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Public Health in Practice (Oxford, England)|September 14, 2022
Increasing rate of diagnosed childhood mental illness in the United States: Incidence, prevalence and costsJoseph Tkacz, Brenna L Brady
Journal of Substance Abuse Treatment|August 24, 2010
A national study of a telephone support service for patients receiving office-based buprenorphine medication-assisted treatment: study feasibility and sample descriptionCharles Ruetsch, John Cacciola, Joseph Tkacz
The American Journal of Managed Care|December 21, 2019
A claims-based algorithm to reduce relapse and cost in schizophreniaHeidi C Waters, Charles Ruetsch, Joseph Tkacz
Value in Health Regional Issues|April 3, 2026
Healthcare Resource Utilization and Costs After Disease Progression With First-Line Systemic Therapy in Patients With Advanced Endometrial Cancer in the United StatesLaura Moore-Schiltz, Solomon J Lubinga, Joseph Tkacz
Journal of Substance Abuse Treatment|December 17, 2013
Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patientsJoseph Tkacz, Joseph Volpicelli, Hyong Un, et al.
The American Journal on Addictions|January 4, 2012
Compliance with buprenorphine medication-assisted treatment and relapse to opioid useJoseph Tkacz, Jamie Severt, John Cacciola, et al.
Journal of Addictive Diseases|May 1, 2012
Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatmentJoseph Tkacz, Jamie Severt, Cheryl Kassed, et al.
The American Journal of Gastroenterology|June 16, 2021
Alarming Trends in Opioid Use Among Patients With GERDColin W Howden, Douglas C A Taylor, Joseph Tkacz
American Health & Drug Benefits|July 4, 2014
Infliximab dosing patterns in a sample of patients with Crohn's disease: results from a medical chart reviewJoseph Tkacz, Jennifer H Lofland, Julie Vanderpoel, et al.
Addictive Behaviors|February 22, 2012
The effect of telephonic patient support on treatment for opioid dependence: outcomes at one year follow-upCharles Ruetsch, Joseph Tkacz, Tracy L McPherson, et al.
Pageof 6